Characteristics of Ischemic Stroke Despite Oral Anticoagulant Use For Atrial Fibrillation.
Marie-Christine DubéCélina DucrouxNicole DaneaultYan DeschaintreGrégory JacquinCéline OdierChristian StapfAlexandre Y PoppeGiovanni RomanelliLaura C GioiaPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
Oral anticoagulation (OAC) prevents stroke in atrial fibrillation, yet a residual stroke risk remains. In this single-center retrospective analysis of acute ischemic stroke patients despite OAC, suboptimal OAC treatment is common (30%: inappropriate dosing (17%); patient non-adherence (13%)). Other causes of stroke included OAC interruption (14.5%), a competing stroke mechanism (11.0%), and undetermined breakthrough stroke in 44.5%. Overall, easily modifiable causes of ischemic stroke despite OAC are common. Accordingly, strategies to improve treatment compliance, including appropriate dosing along with guideline-based risk factor and periprocedural OAC management, should be emphasized to improve secondary stroke prevention in this patient population.
Keyphrases
- atrial fibrillation
- catheter ablation
- oral anticoagulants
- left atrial
- direct oral anticoagulants
- left atrial appendage
- percutaneous coronary intervention
- heart failure
- case report
- liver failure
- skeletal muscle
- intensive care unit
- coronary artery disease
- adipose tissue
- metabolic syndrome
- weight loss
- acute coronary syndrome
- blood brain barrier
- extracorporeal membrane oxygenation
- ischemia reperfusion injury
- replacement therapy
- glycemic control